134 related articles for article (PubMed ID: 36990733)
1. [MIC2 (CD99) as a diagnostic marker for TdT-negative B lymphoblastic lymphoma].
Ikeda N; Imao T; Hisano Y; Kamao T; Uno M; Mizushima T
Rinsho Ketsueki; 2023; 64(2):130-132. PubMed ID: 36990733
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
3. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
Terada T
Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
[TBL] [Abstract][Full Text] [Related]
4. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
Soslow RA; Bhargava V; Warnke RA
Hum Pathol; 1997 Oct; 28(10):1158-65. PubMed ID: 9343323
[TBL] [Abstract][Full Text] [Related]
5. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
6. Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature.
Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Shad AT; Lage JM; Magrath IT; Azumi N; Harris NL; Cossman J; Jaffe ES
Am J Surg Pathol; 1998 Jul; 22(7):795-804. PubMed ID: 9669342
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of anti-terminal deoxynucleotidyl transferase antibody (TdT) in hematologic pathology].
Valmary S; Danjoux M; Delsol G; Brousset P
Ann Pathol; 2005 Feb; 25(1):25-32. PubMed ID: 15981929
[TBL] [Abstract][Full Text] [Related]
8. Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient.
Brčić I; Labar B; Perić-Balja M; Bašić-Kinda S; Nola M
Int J Hematol; 2008 Sep; 88(2):189-191. PubMed ID: 18512118
[TBL] [Abstract][Full Text] [Related]
9. Absence of terminal deoxynucleotidyl transferase expression in T-ALL/LBL accumulates chromosomal abnormalities to induce drug resistance.
Xiao H; Wang S; Tang Y; Li S; Jiang Y; Yang Y; Zhang Y; Han Y; Wu X; Zheng L; Li Y; Gao Y
Int J Cancer; 2023 Jun; 152(11):2383-2395. PubMed ID: 36757202
[TBL] [Abstract][Full Text] [Related]
10. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma.
Zhou Y; Fan X; Routbort M; Cameron Yin C; Singh R; Bueso-Ramos C; Thomas DA; Milton DR; Medeiros LJ; Lin P
Mod Pathol; 2013 Oct; 26(10):1338-45. PubMed ID: 23702731
[TBL] [Abstract][Full Text] [Related]
11. BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
Soslow RA; Zukerberg LR; Harris NL; Warnke RA
Mod Pathol; 1997 Aug; 10(8):810-7. PubMed ID: 9267824
[TBL] [Abstract][Full Text] [Related]
12. Terminal deoxynucleotidyl transferase (TdT)-negative T-cell lymphoblastic lymphoma with loss of the T-cell lineage-specific marker CD3 at relapse: a rare entity with an aggressive outcome.
Hassan M; Abdullah HMA; Wahid A; Qamar MA
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29884716
[TBL] [Abstract][Full Text] [Related]
13. Pitfall in the use of terminal deoxynucleotidyl transferase (TdT) in the cytological diagnosis of lymphoma.
Ingoldsby H; Billett P; Leader M
Histopathology; 2013 Jan; 62(2):359-60. PubMed ID: 23020221
[No Abstract] [Full Text] [Related]
14. Terminal Deoxynucleotidyl Transferase (TdT)-negative Lymphoblastic Leukemia in Pediatric Patients: Incidence and Clinical Significance.
Yasmeen S; Rajkumar A; Grossman H; Szallasi A
Pediatr Dev Pathol; 2017; 20(6):463-468. PubMed ID: 29187045
[TBL] [Abstract][Full Text] [Related]
15. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
[TBL] [Abstract][Full Text] [Related]
16. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma.
Suzumiya J; Ohshima K; Kikuchi M; Takeshita M; Akamatsu M; Tashiro K
J Pathol; 1997 May; 182(1):86-91. PubMed ID: 9227346
[TBL] [Abstract][Full Text] [Related]
17. Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma: a study of 15 cases.
Long JC; McCaffrey RP; Aisenberg AC; Marks SM; Kung PC
Cancer; 1979 Dec; 44(6):2127-39. PubMed ID: 315816
[TBL] [Abstract][Full Text] [Related]
18. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
Faber J; Kantarjian H; Roberts MW; Keating M; Freireich E; Albitar M
Arch Pathol Lab Med; 2000 Jan; 124(1):92-7. PubMed ID: 10629138
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous involvement as the first manifestation of T-lymphoblastic lymphoma and review of the literature.
Montes-Torres A; Llamas-Velasco M; Capusan TM; Aguado B; Adrados M
J Cutan Pathol; 2019 May; 46(5):372-375. PubMed ID: 30680766
[TBL] [Abstract][Full Text] [Related]
20. Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall.
Buresh CJ; Oliai BR; Miller RT
Am J Clin Pathol; 2008 Jun; 129(6):894-8. PubMed ID: 18480005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
